SG11201705598VA - Assay to detect human dpp-4 - Google Patents

Assay to detect human dpp-4

Info

Publication number
SG11201705598VA
SG11201705598VA SG11201705598VA SG11201705598VA SG11201705598VA SG 11201705598V A SG11201705598V A SG 11201705598VA SG 11201705598V A SG11201705598V A SG 11201705598VA SG 11201705598V A SG11201705598V A SG 11201705598VA SG 11201705598V A SG11201705598V A SG 11201705598VA
Authority
SG
Singapore
Prior art keywords
assay
detect human
human dpp
dpp
detect
Prior art date
Application number
SG11201705598VA
Other languages
English (en)
Inventor
Chien-Ying Chang
Xiaodong Xiao
Partha Chowdhury
Original Assignee
Medimmune Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Llc filed Critical Medimmune Llc
Publication of SG11201705598VA publication Critical patent/SG11201705598VA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565Complementarity determining region [CDR]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
SG11201705598VA 2015-01-09 2016-01-08 Assay to detect human dpp-4 SG11201705598VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562101697P 2015-01-09 2015-01-09
PCT/US2016/012603 WO2016112261A2 (en) 2015-01-09 2016-01-08 Assay to detect human dpp-4

Publications (1)

Publication Number Publication Date
SG11201705598VA true SG11201705598VA (en) 2017-08-30

Family

ID=56356576

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201705598VA SG11201705598VA (en) 2015-01-09 2016-01-08 Assay to detect human dpp-4

Country Status (14)

Country Link
US (2) US10351630B2 (pt)
EP (1) EP3242686B1 (pt)
JP (1) JP2018502577A (pt)
KR (1) KR20170098941A (pt)
CN (1) CN107206079A (pt)
AU (1) AU2016205188A1 (pt)
BR (1) BR112017011724A2 (pt)
CA (1) CA2970540A1 (pt)
HK (2) HK1243953A1 (pt)
IL (1) IL252528A0 (pt)
MX (1) MX2017008748A (pt)
RU (1) RU2017127182A (pt)
SG (1) SG11201705598VA (pt)
WO (1) WO2016112261A2 (pt)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681718A (en) 1986-03-14 1997-10-28 Celltech Limited Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof
US5892019A (en) 1987-07-15 1999-04-06 The United States Of America, As Represented By The Department Of Health And Human Services Production of a single-gene-encoded immunoglobulin
US7115555B2 (en) * 1998-07-09 2006-10-03 Baylor College Of Medicine Hypohidrotic ectodermal dysplasia genes and proteins
US6573096B1 (en) * 2000-04-01 2003-06-03 The Research Foundation At State University Of New York Compositions and methods for inhibition of cancer invasion and angiogenesis
CN101172158A (zh) * 2001-05-11 2008-05-07 得克萨斯州立大学董事会 抗cd26单克隆抗体作为对与表达cd26的细胞相关疾病的治疗
GB0216648D0 (en) 2002-07-18 2002-08-28 Lonza Biologics Plc Method of expressing recombinant protein in CHO cells
EP1631680A2 (en) 2003-05-21 2006-03-08 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4)
GB0407315D0 (en) 2003-07-15 2004-05-05 Cambridge Antibody Tech Human antibody molecules
WO2005075514A2 (en) 2004-03-10 2005-08-18 Lonza Ltd. Method for producing antibodies
JP4997239B2 (ja) * 2005-07-22 2012-08-08 ワイズ・エー・シー株式会社 抗cd26抗体およびその使用方法
US20090155784A1 (en) 2007-01-22 2009-06-18 Wyeth Assessment of asthma and allergen-dependent gene expression
JP6161233B2 (ja) 2008-03-31 2017-07-12 ジェネンテック, インコーポレイテッド 喘息の治療及び診断のための組成物及び方法
US20100221752A2 (en) 2008-10-06 2010-09-02 Somalogic, Inc. Ovarian Cancer Biomarkers and Uses Thereof
WO2012031122A2 (en) * 2010-09-03 2012-03-08 Immport Therapeutics, Inc. Methods and compositions for the diagnosis and treatment of cancer and autoimmune disorders
JP2013544235A (ja) 2010-10-15 2013-12-12 メドイミューン・リミテッド 肺機能を改善する治療法
CN105175542B (zh) 2010-12-16 2018-12-18 弗·哈夫曼-拉罗切有限公司 与th2抑制相关的诊断和治疗
EP2710370A4 (en) 2011-05-18 2015-01-07 Medimmune Llc METHODS OF DIAGNOSING AND TREATING PULMONARY DISEASES OR DISORDERS
JP2017509692A (ja) 2014-01-27 2017-04-06 メディミューン,エルエルシー 喘息肺におけるil−13活性化の末梢バイオマーカーとしてのジペプチジルペプチターゼ4(dpp4/cd26)

Also Published As

Publication number Publication date
AU2016205188A1 (en) 2017-06-22
EP3242686A2 (en) 2017-11-15
CA2970540A1 (en) 2016-07-14
JP2018502577A (ja) 2018-02-01
HK1244444A1 (zh) 2018-08-10
MX2017008748A (es) 2017-11-17
HK1243953A1 (zh) 2018-07-27
WO2016112261A2 (en) 2016-07-14
IL252528A0 (en) 2017-07-31
US20160200832A1 (en) 2016-07-14
RU2017127182A (ru) 2019-02-11
EP3242686A4 (en) 2018-06-06
US10351630B2 (en) 2019-07-16
US20190352425A1 (en) 2019-11-21
EP3242686B1 (en) 2020-07-08
BR112017011724A2 (pt) 2018-05-15
KR20170098941A (ko) 2017-08-30
CN107206079A (zh) 2017-09-26
WO2016112261A3 (en) 2016-09-01

Similar Documents

Publication Publication Date Title
GB201508074D0 (en) People detection
GB201403820D0 (en) Assay
PL3099791T3 (pl) Białko
HK1232238A1 (zh) 檢測人類骨膜蛋白的新型測定
PL3129001T3 (pl) Preparat alergenów wolny od hsp
GB201415344D0 (en) Protein
PL3099793T3 (pl) Białko
GB201517458D0 (en) Assay
HK1247236A1 (zh) 效能分析
GB201518675D0 (en) Detection of structural forms of proteins
GB201411506D0 (en) Modified latency associated protein construct
ZA201607732B (en) Assay to determine anticoagulants in blood or blood plasma
SG11201800037WA (en) Sensor connection structure
GB201419072D0 (en) Assay
GB201415343D0 (en) Blomarker assay
HK1244444A1 (zh) 檢測人dpp-4的測定法
GB201517390D0 (en) Protein variant analysis
GB201511725D0 (en) Assay
EP2989216A4 (en) PRÄAMPLIFIKATIONSTEST
PL3094338T3 (pl) Oznaczenie i lek
GB201521450D0 (en) Assay construct
GB201510017D0 (en) Activity assay
GB201512737D0 (en) Assay
GB201509300D0 (en) Assay
GB201501612D0 (en) Assay